coopervision lt eye delay annual meet coopervision inc say delay annual meet june 22 may 14 allow board review possible recapitalization option meet coopervision today report first quarter net income 64 6 mln dlrs 175 2 mln dlr pretax gain sale ophthalmic business johnson johnson lt jnj 260 mln dlrs cash 17 9 mln dlr posttax charge debt repurchase sale 94 4 mln dlrs year earlier earn 7 300 000 dlrs 120 000 dlr loss discontinue operation sale 85 4 mln dlrs company say aggressive program investment spend maintain increase market share two core business accelerate sale growth year hold back increase operate income near future coopervision say furthermore entire net cash proceed recent sale several business employ reduce indebtedness make strategic acquisition otherwise employ relation possible recapitalization company recovery net income hold back loss particularly tax income ophthalmic pharmaceutical business sell johnson johnson ." 